Fibromyalgia Treatment Global Market Report 2024

Description

“Fibromyalgia Treatment Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on fibromyalgia treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for fibromyalgia treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The fibromyalgia treatment market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Type: Symptomatic Treatment; Targeted Treatment
2) By Drug Class: Antidepressants; Antiepileptics; Muscle Relaxants; Analgesics; Other Drugs
3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
Companies Mentioned: Pfizer Inc.; Johnson and Johnson Services Inc.; Roche Holding AG; AbbVie Inc.; Novartis AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Fibromyalgia treatment encompasses the use of medications to address fibromyalgia, a multifaceted and persistent medical condition primarily characterized by widespread and often debilitating musculoskeletal pain, coupled with a range of other symptoms. The objective of fibromyalgia treatment is to mitigate the severity of the condition and effectively manage the associated symptoms and complications.

The primary categories of fibromyalgia treatment involve symptomatic treatment and targeted treatment. Symptomatic treatment, also referred to as palliative or supportive care, is geared towards addressing individual symptoms and enhancing the overall quality of life for patients. Various drug classes, including antidepressants, antiepileptics, muscle relaxants, analgesics, and others, are available and distributed through diverse channels such as hospital pharmacies, retail pharmacies, and online pharmacies.

The fibromyalgia treatment market research report is one of a series of new reports from The Business Research Company that provides fibromyalgia treatment market statistics, including fibromyalgia treatment industry global market size, regional shares, competitors with a fibromyalgia treatment market share, detailed fibromyalgia treatment market segments, market trends and opportunities and any further data you may need to thrive in the fibromyalgia treatment industry. This fibromyalgia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The fibromyalgia treatment market size has grown steadily in recent years. It will grow from $2.66 billion in 2023 to $2.79 billion in 2024 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to increasing prevalence of fibromyalgia, growing awareness about fibromyalgia, government initiatives, rising disposable incomes.

The fibromyalgia treatment market size is expected to see steady growth in the next few years. It will grow to $3.28 billion in 2028 at a compound annual growth rate (CAGR) of 4.1%. The growth in the forecast period can be attributed to growing geriatric population, rising healthcare expenditure, rising occurrence of musculoskeletal disorders, increasing research and development activities to develop better treatment. Major trends in the forecast period include advancements in treatment options, strategic collaborations, advancements in integration of technology, innovative treatments.

The fibromyalgia market is poised for growth due to increasing government actions and initiatives focused on musculoskeletal health. These government actions encompass a range of policies and programs aimed at improving the well-being of individuals affected by musculoskeletal conditions. For example, in 2022, Musculoskeletal Australia, an organization based in Australia, reported that the Australian government launched the "Own Your Health" initiative. This four-year initiative is dedicated to promoting self-care and supporting individuals dealing with musculoskeletal conditions. Hence, the growing emphasis on musculoskeletal health through government initiatives is a driving force behind the expansion of the fibromyalgia market.

The growth of the fibromyalgia treatment market is significantly influenced by the expanding aging population. This demographic shift is characterized by a rising percentage of elderly individuals within society or a given population. The aging population is particularly relevant to the fibromyalgia treatment market as older individuals are more prone to developing fibromyalgia, and they often face more severe symptoms due to age-related factors. For instance, the United Nations Department of Economic and Social Affairs reported in July 2022 that the global population's proportion aged 65 and older is projected to increase from 10% in 2022 to 16% by 2050. Consequently, the growing aging population is a key driver behind the expansion of the fibromyalgia treatment market.

The growth of the fibromyalgia treatment market is impeded by the high cost of treatments during the forecast period. Patients who bear the burden of high treatment costs may exhibit reduced adherence to prescribed treatment regimens. This reduced adherence can lead to suboptimal management of fibromyalgia symptoms and ultimately result in poorer health outcomes. For example, data from Fitsit i.o in June 2023 revealed that 5% of individuals were affected by at least one musculoskeletal ailment, incurring an average cost of $1614.81 (€1,524) per person. Among these conditions, low back pain was the most costly, with an average per capita cost of $2548.3 (€2,405), followed by neck discomfort, which had a per capita cost of $2394.66 (€2,260). The total adjusted healthcare expenditure for musculoskeletal illnesses exceeded $3.18 (€3) billion annually. Consequently, the high treatment costs act as a hindrance to the growth of the fibromyalgia treatment market.

Prominent companies within the fibromyalgia treatment market are prioritizing the development of cutting-edge solutions, such as microchip technology, to maintain their competitive edge in the industry. Proprietary microchip technology is a specific category that harnesses the potential of microchips to deliver precise and targeted nerve stimulation, thereby alleviating symptoms associated with fibromyalgia. Notably, in November 2022, NeuroMetrix Inc., a US-based medical equipment manufacturer, introduced the Quell Fibromyalgia device as part of its Pathfinder Program, presenting a groundbreaking solution for managing fibromyalgia symptoms. Distinguished as the first and only medical device sanctioned by the U.S. Food and Drug Administration (FDA) for mitigating fibromyalgia symptoms, the Quell Fibromyalgia device employs transcutaneous electrical nerve stimulation (TENS). This device leverages proprietary microchip technology to administer accurate, high-intensity nerve stimulation in a compact, wearable design, optimized through position and motion sensing.

In April 2023, the U.S.-based telemedicine company XRHealth merged with Spain-based VR treatment solutions provider Amelia Virtual Care, operating under the XRHealth brand. This merger marks the unification of XRHealth and Amelia Virtual Care, creating a synergistic entity that allows the two companies to leverage their expertise, technologies, and resources. The collaboration integrates XRHealth's immersive and augmented reality technology with Amelia Virtual Care's extensive virtual reality software designed for mental health professionals.

Major players in the fibromyalgia treatment market are Pfizer Inc., Johnson and Johnson Services Inc., Roche Holding AG, AbbVie Inc., Novartis AG, Sanofi S.A., AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Co. Ltd., Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Ltd., Horizon Therapeutics PLC, Endo International PLC, Amneal Pharmaceuticals Inc., Zydus Lifesciences Limited, Lupin Limited .

North America was the largest region in the fibromyalgia market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in fibromyalgia treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the fibromyalgia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The fibromyalgia treatment market consists of revenues earned by providing medical diagnosis and evaluation, personalized treatment planning, medication management, pain management clinics and physical therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The fibromyalgia treatment market also includes sales of pain relievers, sleeping aids and anti-anxiety medications. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r12279

1. Executive Summary

2. Fibromyalgia Treatment Market Characteristics

3. Fibromyalgia Treatment Market Trends And Strategies

4. Fibromyalgia Treatment Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Fibromyalgia Treatment Market Size and Growth

5.1. Global Fibromyalgia Treatment Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Fibromyalgia Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Fibromyalgia Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Fibromyalgia Treatment Market Segmentation

6.1. Global Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Symptomatic Treatment
Targeted Treatment
6.2. Global Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Antidepressants
Antiepileptics
Muscle Relaxants
Analgesics
Other Drugs
6.3. Global Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

7. Fibromyalgia Treatment Market Regional And Country Analysis

7.1. Global Fibromyalgia Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Fibromyalgia Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Fibromyalgia Treatment Market

8.1. Asia-Pacific Fibromyalgia Treatment Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Fibromyalgia Treatment Market

9.1. China Fibromyalgia Treatment Market Overview
9.2. China Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Fibromyalgia Treatment Market

10.1. India Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Fibromyalgia Treatment Market

11.1. Japan Fibromyalgia Treatment Market Overview
11.2. Japan Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Fibromyalgia Treatment Market

12.1. Australia Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Fibromyalgia Treatment Market

13.1. Indonesia Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Fibromyalgia Treatment Market

14.1. South Korea Fibromyalgia Treatment Market Overview
14.2. South Korea Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Fibromyalgia Treatment Market

15.1. Western Europe Fibromyalgia Treatment Market Overview
15.2. Western Europe Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Fibromyalgia Treatment Market

16.1. UK Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Fibromyalgia Treatment Market

17.1. Germany Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Fibromyalgia Treatment Market

18.1. France Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Fibromyalgia Treatment Market

19.1. Italy Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Fibromyalgia Treatment Market

20.1. Spain Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Fibromyalgia Treatment Market

21.1. Eastern Europe Fibromyalgia Treatment Market Overview
21.2. Eastern Europe Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Fibromyalgia Treatment Market

22.1. Russia Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Fibromyalgia Treatment Market

23.1. North America Fibromyalgia Treatment Market Overview
23.2. North America Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Fibromyalgia Treatment Market

24.1. USA Fibromyalgia Treatment Market Overview
24.2. USA Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Fibromyalgia Treatment Market

25.1. Canada Fibromyalgia Treatment Market Overview
25.2. Canada Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Fibromyalgia Treatment Market

26.1. South America Fibromyalgia Treatment Market Overview
26.2. South America Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Fibromyalgia Treatment Market

27.1. Brazil Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Fibromyalgia Treatment Market

28.1. Middle East Fibromyalgia Treatment Market Overview
28.2. Middle East Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Fibromyalgia Treatment Market

29.1. Africa Fibromyalgia Treatment Market Overview
29.2. Africa Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Fibromyalgia Treatment Market Competitive Landscape And Company Profiles

30.1. Fibromyalgia Treatment Market Competitive Landscape
30.2. Fibromyalgia Treatment Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Johnson and Johnson Services Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Roche Holding AG
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. AbbVie Inc.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Novartis AG
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Fibromyalgia Treatment Market Other Major And Innovative Companies

31.1. Sanofi S.A.
31.2. AstraZeneca plc
31.3. Abbott Laboratories
31.4. GlaxoSmithKline plc
31.5. Eli Lilly and Company
31.6. Amgen Inc.
31.7. Viatris Inc.
31.8. Teva Pharmaceutical Industries Ltd.
31.9. Regeneron Pharmaceuticals Inc.
31.10. Mylan N.V.
31.11. Astellas Pharma Inc.
31.12. Biogen Inc.
31.13. Daiichi Sankyo Co. Ltd.
31.14. Boehringer Ingelheim International GmbH
31.15. Sun Pharmaceutical Industries Ltd.

32. Global Fibromyalgia Treatment Market Competitive Benchmarking

33. Global Fibromyalgia Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Fibromyalgia Treatment Market

35. Fibromyalgia Treatment Market Future Outlook and Potential Analysis

35.1 Fibromyalgia Treatment Market In 2028 - Countries Offering Most New Opportunities
35.2 Fibromyalgia Treatment Market In 2028 - Segments Offering Most New Opportunities
35.3 Fibromyalgia Treatment Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer